TY  - GEN
AU  - Dirschka,T
AU  - Radny,P
AU  - Dominicus,R
AU  - Mensing,H
AU  - Brüning,H
AU  - Jenne,L
AU  - Karl,L
AU  - Sebastian,M
AU  - Oster-Schmidt,C
AU  - Klövekorn,W
AU  - Reinhold,U
AU  - Tanner,M
AU  - Gröne,D
AU  - Deichmann,M
AU  - Simon,M
AU  - Hübinger,F
AU  - Hofbauer,G
AU  - Krähn-Senftleben,G
AU  - Borrosch,F
AU  - Reich,K
AU  - Berking,C
AU  - Wolf,P
AU  - Lehmann,P
AU  - Moers-Carpi,M
AU  - Hönigsmann,H
AU  - Wernicke-Panten,K
AU  - Hahn,S
AU  - Pabst,G
AU  - Voss,D
AU  - Foguet,M
AU  - Schmitz,B
AU  - Lübbert,H
AU  - Szeimies,R-M
TI  - Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis
SN  - 1365-2133
PY  - 2013///0919
KW  - Aged
KW  - Aged, 80 and over
KW  - Aminolevulinic Acid
KW  - administration & dosage
KW  - Drug Therapy, Combination
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Keratosis, Actinic
KW  - drug therapy
KW  - Long-Term Care
KW  - Male
KW  - Middle Aged
KW  - Photochemotherapy
KW  - methods
KW  - Photosensitizing Agents
KW  - Prospective Studies
KW  - Recurrence
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/bjd.12158
ER  -